Suchergebnisse - "Spinelli, Matthew A"

PubPharm (85)

1

Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID

enthalten in: bioRxiv.org | 2024

von Peluso, M. | Deveau, T. | Munter, S. | +29

2

Association of SARS-CoV-2 Infection and Cardiopulmonary Long COVID with Exercise Capacity and Chronotropic Incompetence among People with HIV

enthalten in: bioRxiv.org | 2024

von Durstenfeld, M. | Peluso, M. | Spinelli, M. | +8

3

Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus : An Interrupted Time Series Analysis

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Spinelli, M. | Christopoulos, K. | Moreira, C. | +13

4

Plasma-based antigen persistence in the post-acute phase of COVID-19

enthalten in: The Lancet. Infectious diseases | 2024

von Peluso, M. | Swank, Z. | Goldberg, S. | +22

UpdateOf: medRxiv. 2023 Dec 29;:. - PMID 37961239

5

Pandemic expertise : qualitative findings on the experiences of living with HIV during the COVID-19 pandemic

enthalten in: AIDS care | 2024

von Mars, S. | Spinelli, M. | Ondocsin, J. | +6

6

Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection

enthalten in: bioRxiv.org | 2024

von Peluso, M. | Swank, Z. | Goldberg, S. | +22

7

Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection

enthalten in: medRxiv : the preprint server for health sciences | 2023

von Peluso, M. | Swank, Z. | Goldberg, S. | +22

UpdateIn: Lancet Infect Dis. 2024 Apr 8;:. - PMID 38604216

8

Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding : a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial

enthalten in: The lancet. HIV | 2023

von Landovitz, R. | Hanscom, B. | Clement, M. | +28

CommentIn: Lancet HIV. 2023 Dec;10(12):e756-e757. - PMID 37952552

9

Urine point-of-care tenofovir test demonstrates strong predictive clinical and research utility

enthalten in: AIDS (London, England) | 2023

von Mustanski, B. | Ryan, D. | Spinelli, M. | +2

10

Adherence determination using urine-tenofovir point-of-care testing and pharmacy refill records : A cross-sectional study

enthalten in: Medicine | 2023

von Herbertson, E. | Lahiri, C. | Olugbake, O. | +3

1
2
3
4
5
6
7
8
9
Nächster »
[9]